Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

Nakamoto Inc.NASDAQ: NAKA

Other Stockholders Equity · Q1 FY2026 · quarter ended Mar 2026

Other stockholders equity remains negative

Q1 FY2026 other stockholders equity was $0, compared with $0 a year earlier.

Context

  • Other stockholders equity amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Other stockholders equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Other Stockholders Equity vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's Mar 2026 other stockholders equity of $0 is the 2nd highest of the 11 companies compared; the peer median is $0.
  • Other stockholders equity amounts to 0.0% of total assets for NAKA, versus a peer median of 0.0%.
NAKA Competitors Peer median
Other Stockholders Equity for NAKA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CLLSCellectis S.A.Mar 2026$1K ——0.0%
NAKANakamoto Inc.Mar 2026$0 ——0.0%
AGLAgilon Health, Inc.Mar 2026$0 ——0.0%
DCTHDelcath Systems, Inc.Mar 2026$0 ——0.0%
SOPHSOPHiA GENETICS S.A.Mar 2026$0 ——0.0%
SLPSimulations Plus, Inc.Feb 2026$0 ——0.0%
LYELLyell Immunopharma, Inc.Mar 2026$0 -100.0%—0.0%
LRMRLarimar Therapeutics, Inc.Mar 2026$0 ——0.0%
AMRNAmarin Corporation plcMar 2026$0 ——0.0%
DHDefinitive Healthcare Corp.Mar 2026$0 ——0.0%
DBVTDBV Technologies S.A.Mar 2026-$100K ——0.0%
Peer median (excluding NAKA) $0-100.0%—0.0%

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents94.69K186.92K525.5K2.27M22.58M
Short-term Investments00000
Net Receivables13.47K12.12K28K36.85K2.82K
Inventory59.77K49.57K63.2K4.3K0
Other Current Assets101.51K60.96K2250199.06M
Total Current Assets269.44K309.57K616.93K2.51M223.82M
Property, Plant & Equipment (Net)171.57K622.93K471K764.58K0
Goodwill00000
Intangible Assets000388.34K470.56M
Long-term Investments6.63K00035.7M
Tax Assets00000
Other Non-current Assets014.51K11.28K19.43K534.3K
Total Non-current Assets178.2K637.43K482.27K1.17M506.79M
Total Assets447.64K947K1.1M3.68M730.61M
Account Payables47.5K00323.73K5.86M
Short-term Debt53.54K92.55K148.52K139.28K209.56M
Tax Payables00000
Deferred Revenue17.25K8.6K3.43K2.28K0
Other Current Liabilities0166.26K567.81K0568.21K
Total Current Liabilities118.29K327.9K814.45K606.05K215.99M
Long-term Debt00228.87K00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities56.27K238.09K393.17K503.63K365.97K
Total Liabilities174.56K565.98K1.21M1.11M216.35M
Common Stock273.09K4.43K4.62K6.05K439.95K
Retained Earnings0(2.54M)(4.16M)(7.78M)(60M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity273.09K381.01K(108.41K)2.57M514.26M
Total Debt109.81K391.13K636.38K783.68K209.92M
Net Debt15.12K204.21K110.88K(1.49M)187.34M

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.